05-2025-12-08-LLY-Downtrend-Short-7LLY:
Short Position with Downtrend
Scorecard: 7
S: 1,023.87
E: 1,005.33
T: 993.21
Shares: 5.39
Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs
No trades
Key facts today
425 ARS
9.70 T ARS
41.24 T ARS
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
Identifiers
2
ISIN:ARDEUT111192
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Related stocks
Eli Lilly May Be OversoldEli Lilly surged last month, and now it’s pulled back.
The first pattern on today’s chart is the 50 percent retracement of the advance. That may suggest its direction is pointing higher. Prices have also stabilized at the psychologically important $1,000 level.
Second, the 50-day simple moving ave
LLY - looking to reach the previous high ?=======
Volume
=======
-slight decreasing volume
==========
Price Action
==========
- Latest downtrend broken
- Change of trend observed
=========
Oscillators
=========
- Ichimoku, price above cloud, green kumo expanding, base + conv + lagging above sign of piercing clouds
- MACD still bullish
$LLYThe technical structure for NYSE:SMR presents a compelling case of a strong, sustained uptrend, characterized by a rhythmic pattern of sharp advances followed by periods of consolidation. This behavior is the hallmark of a healthy, momentum-driven bull move.
1. Pattern Analysis: Sequential Bull F
Lilly (NYSE: $LLY) Jumps as FDA Expands Jaypirca UseEli Lilly and Company (NYSE: NYSE:LLY ) received a major regulatory boost after the U.S. Food and Drug Administration approved an expanded indication for its non-covalent BTK inhibitor, Jaypirca (pirtobrutinib). The drug is now approved for adults with relapsed or refractory chronic lymphocytic leu
Bullish Flag Pattern!LLY
Closed at 802.83 (17-10-2025)
Bullish Flag Pattern in play.
It may Target 1250+ if 972 - 973
is Crossed & Sustained.
Should not break 623 now, else
we may witness further selling pressure.
$LLY probably back to $1000Took full profits on NYSE:LLY , did not want to see this overshoot and a reversal. Short term it's going back to $1000 first, probably.
LLY NOV 2025LLY extending in markup, demand absorption at 935-885 support.
Upside target 1120; downside 885 then 740 if it fails.
#LLY #globaltrade #investment #investing #stockmarket #wealth #realestate #markets #economy #finance #money #forex #trading #price #business #currency
Eli Lilly (LLY) Shares Have Surged by Around 30% in NovemberEli Lilly (LLY) Shares Have Surged by Around 30% in November
The price action of Eli Lilly and Company (LLY), the world’s largest pharmaceutical firm, reflects exceptionally strong demand:
→ since the start of the month, LLY shares have risen by roughly 30%;
→ in late November, the company’s marke
LLY Hits Major Resistance: Breakout to $1300 or Pullback Ahead?LLY is moving inside a strong long-term ascending channel, and the price has now reached the upper resistance boundary of the purple channel.
This is a major decision zone:
Either a breakout occurs and momentum continues strongly upward,
or the price gets rejected and pulls back inside the channe
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS238628644
Eli Lilly and Company 1.625% 14-SEP-2043Yield to maturity
5.67%
Maturity date
Sep 14, 2043
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044Yield to maturity
5.65%
Maturity date
Jun 15, 2044
US532457BU1
Eli Lilly and Company 4.15% 15-MAR-2059Yield to maturity
5.56%
Maturity date
Mar 15, 2059
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065Yield to maturity
5.52%
Maturity date
Feb 12, 2065
LLY6153503
Eli Lilly and Company 5.65% 15-OCT-2065Yield to maturity
5.51%
Maturity date
Oct 15, 2065
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064Yield to maturity
5.51%
Maturity date
Feb 9, 2064
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064Yield to maturity
5.50%
Maturity date
Aug 14, 2064
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
5.48%
Maturity date
Feb 27, 2063
LLYH
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
5.48%
Maturity date
May 15, 2047
US532457BT4
Eli Lilly and Company 3.95% 15-MAR-2049Yield to maturity
5.47%
Maturity date
Mar 15, 2049
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053Yield to maturity
5.44%
Maturity date
Feb 27, 2053
See all LLY bonds
